aeruginosa’s main QS molecule, N- (3-Oxododecanoyl)-L-homoserine lactone, induces
Management of recurrent vulvovaginal candidiasis (RVVC) is an unmet clinical challenge without approved treatment in the United States
The synergy of fluconazole when combined with Fusidic acid was investigated by determination of minimum inhibitory concentration
03 to 0
The synergy of fluconazole when combined with Fusidic acid was investigated by determination of minimum inhibitory concentration
(2) Methods:
1111/myc
One reference strain (ATCC90028) Determination of minimum inhibitory concentration (MIC) The chosen concentration of fluconazole is the minimum concentration required to inhibit 80% of C
Reliable assessment of MIC has a significant impact on the choice of a therapeutic strategy, which affects efficiency of an infection therapy
For this purpose, the enzyme-linked immunoassay 96-well microplates were utilized; 10 wells were used for 0
We tested 39 selected Candida species (in vitro susceptible: fluconazole MIC of ≤1 μg/ml, and resistant: fluconazole MIC of ≥8 μg/ml) and to fluconazole Table 2
1%) of whom had an elevated minimum inhibitory concentration (MIC) to fluconazole (MIC ≥16 µg/mL)
Cyclosporine A decreases the fluconazole minimum inhibitory To evaluate the impacts of fluconazole minimum inhibitory concentration (MIC) according to primary antifungal agents on Candida glabrata bloodstream infection (BSI), a multicenter retrospective cohort study was conducted in Korea, concerning the time period from January 2010 to February 2016
All values are against C
Crl:CD1 (ICR) BR mice were colonized in the gastrointestinal (GI) tract with Candida albicans